Vijaya Diagnostic Centre vs Peers
- Market cap
- ₹15,177 crore
- P/E
- 81.0
- P/B
- 15.86
- ROE
- 19.7%
- Dividend yield
- 0.14%
Vijaya Diagnostic Centre ranks 2nd by market capitalisation among 8 Healthcare Service Provider companies tracked by ATS. Its largest peers are Dr. Lal Path Labs, Metropolis Healthcare and Thyrocare Technologies. Its P/E of 81.0 compares with a peer median of 46.6.
Vijaya Diagnostic Centre vs Healthcare Service Provider peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 1,950.50 | -0.70% | 32,569 | 60.1 | 12.99 | 21.6% | +12.5% |
| Vijaya Diagnostic Centre | 1,475.00 | +0.57% | 15,177 | 81.0 | 15.86 | 19.7% | +22.0% |
| Metropolis Healthcare | 545.00 | -1.38% | 11,299 | 56.0 | 7.47 | 13.4% | +12.5% |
| Thyrocare Technologies | 516.55 | -2.50% | 8,222 | 46.6 | 14.04 | 28.8% | +12.5% |
| Nephrocare Health Services | 643.15 | +1.36% | 6,453 | 75.8 | 5.78 | 9.0% | +12.5% |
| 3B Blackbio Dx | 1,640.70 | +4.16% | 1,408 | 25.4 | 4.34 | 20.2% | +12.5% |
| Health X Platform | 284.15 | -0.28% | 904 | 22.5 | 1.41 | 0.2% | +12.5% |
| Gaudium IVF and Women Health | 107.50 | -1.63% | 782 | 33.7 | 3.20 | 16.4% | +12.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 7 October 2026. How this data is compiled.
Vijaya Diagnostic Centre peer comparison — frequently asked questions
Who are Vijaya Diagnostic Centre's competitors?
Vijaya Diagnostic Centre's listed peers in Healthcare Service Provider include Dr. Lal Path Labs, Metropolis Healthcare, Thyrocare Technologies, Nephrocare Health Services, 3B Blackbio Dx and Health X Platform, ranked here by market capitalisation.
How does Vijaya Diagnostic Centre's P/E compare with its peers?
Vijaya Diagnostic Centre trades at a P/E of 81.0, against a median of 46.6 across the 7 Healthcare Service Provider peers shown.
Which is the largest company among Vijaya Diagnostic Centre's peers?
By market capitalisation, the largest company in the group is Dr. Lal Path Labs at ₹32,569 crore, against ₹15,177 crore for Vijaya Diagnostic Centre.
Same Data For Peers
Trade Vijaya Diagnostic Centre With ATS
Track VIJAYA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.